Aprecia Pharmaceuticals Inc., of Langhorne, Pa., appointed Timothy Tracy CEO, effective January 2018.
Astellas Pharma Inc., of Tokyo, appointed Nate Crisel vice president, real world informatics and analytics; Gary Thal vice president, specialty, medical affairs, Americas; James Miteff national vice president, health systems payer and channel account management; and Gregory Apostol national vice president, key account management.
Atyr Pharma Inc., of San Diego, named Sanjay Shukla president and CEO.
Basilea Pharmaceutica Ltd., of Basel, Switzerland, named Marc Engelhardt chief medical officer, effective Jan. 1, 2018.
Biovie Inc., of Beverly, Mass., added Mina Sooch to its board.
Cambridge Epigenetix Ltd., of Cambridge, U.K., appointed Hayden Jeffreys chief operating officer, and Joanne Mason vice president of biomarker discovery.